Inference startup Inferact lands $150M to commercialize vLLM

The seed round values the newly formed startup at $800 million.

Inferact launches with $150M in funding to commercialize vLLM

Inferact’s founding team includes computer science professor and Databricks co-founder Ion Stoica. He is currently the ...

Cincinnati tech company plans to commercialize 3D models of X-ray, MRI scans

A Cincinnati-based technology company plans to commercialize its technology creating 3D models of X-rays and MRI scans for ...
Morningstar

Polyembo Closes Funding to Commercialize New Vascular Embolic Technology

Novel embolic device designed to obstruct or reduce blood flow, Funded by Strategic Investor. DENVER, Oct. 24, 2025 /PRNewswire/ -- Polyembo, a privately held medical device company founded to develop ...
Nasdaq

Dow and Innventure Collaborate to Develop Waste-to-Value Technologies Through New Subsidiary Refinity

Dow and Innventure have announced a collaboration to develop and commercialize waste-to-value technologies aimed at converting mixed waste, particularly difficult-to-recycle plastics, into ...
Morningstar

Neurimmune expands collaboration with AstraZeneca to develop and commercialize fibril depleter NI009 for AL amyloidosis

ZURICH, Dec. 4, 2025 /PRNewswire/ -- Neurimmune today announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease by ...
Nasdaq

Zealand Pharma, Roche To Co-develop, Co-commercialize Petrelintide And Combination Products

(RTTNews) - Zealand Pharma A/S (ZEAL) announced a global collaboration and license agreement with Roche (RHHBY) to develop petrelintide, Zealand Pharma's amylin analog. The two companies will ...